Adiponectin: Mechanistic insights and clinical implications

Research output: Contribution to journalReview articlepeer-review

485 Scopus citations


Adiponectin is an adipocyte-derived secretory protein that has been very widely studied over the past 15 years. A multitude of different functions have been attributed to this adipokine. It has been characterised in vitro at the level of tissue culture systems and in vivo through genetic manipulation of rodent models. It is also widely accepted as a biomarker in clinical studies. Originating in adipose tissue, generally positive metabolic effects have been attributed to adiponectin. In this review, we briefly discuss the key characteristics of this interesting but very complex molecule, highlight recent results in the context of its mechanism of action and summarise some of the key epidemiological data that helped establish adiponectin as a robust biomarker for insulin sensitivity, cardiovascular disease and many additional disease phenomena.

Original languageEnglish (US)
Pages (from-to)2319-2326
Number of pages8
Issue number9
StatePublished - Sep 2012


  • Adipokines
  • Adiponectin
  • Ceramides
  • Diabetes mellitus
  • Insulin-sensitivity
  • Obesity
  • Review

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Adiponectin: Mechanistic insights and clinical implications'. Together they form a unique fingerprint.

Cite this